Humanigen Inc. (HGEN) Fundamentals

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.
SHARE INFORMATION
Market Cap$ 26,212,168
Shares Outstanding70,633,705
Float59,268,694
Percent Float83.91%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,595,000
Latest Fiscal EPS$ -4.05
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions196
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months2,443,549
Institutional Holdings Percent56.8%
Institutional Sold Previous 3 Months8,838,400
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months4,316,535
Insider Holdings Percent0.8
Insider Sold Previous 3 Months-
Insider Shares Owned579,475
TRADING INFO
52 Week High$ 18.22
52 Week Low$ 0.35
52 Week High Change$ -97.82
21 Day Moving Average$ 0.4107
21 Day Extended Moving Average$ 0.631599
50 Day Moving Average$ 1.4719
50 Day Extended Moving Average$ 1.1969
200 Day Moving Average$ 2.9894
200 Day Extended Moving Average$ 3.7722
10 Day Average Volume10,958,793
20 Day Average Volume13,838,394
30 Day Average Volume14,650,321
50 Day Average Volume9,395,593
Alpha-0.083891
Beta1.4378
Standard Deviation0.343818
R20.046280
7 Day Price Change$ -0.0089
7 Day Percent Change-2.34%
21 Day Price Change$ -0.0905
21 Day Percent Change-19.61%
30 Day Price Change$ -2.65
30 Day Percent Change-87.71%
Month to Date Price Change$ 0.0041
Month to Date Percent Change1.12%
Quarter to Date Price Change$ -1.40
Quarter to Date Percent Change-79.03%
180 Day Price Change$ -1.50
180 Day Percent Change-80.16%
200 Day Price Change$ -2.17
200 Day Percent Change-85.39%
Year to Date Price Change$ -3.35
Year to Date Percent Change-90.02%

Humanigen Inc. (HGEN) Key Ratios

PROFITABILITY
EBIT Margin-4,568.9%
EBITDA Margin-4,568.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 3,109,000
Revenue Per Share$ 0.044
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-1.00
Total Debt To Equity0.60
Int Coverage-63.60
Current Ratio1.00
Leverage Ratio-2.90
Quick Ratio1.00
Long Term Debt To Capital0.36
VALUATION MEASURES
PE Ratio-0.10
Enterprise Value$ -18,192,663
Price to Sales8.4311
Price to Free Cash-0.30
PE High Last 5 Years-0.60
Price To Book8.80
Price To Cash Flow0.00
PE Low Last 5 Years-3.40
Price to Tangible Book-1.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.20
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-233.64
Return on Equity4,286.83
Return on Capital-652.26

Humanigen Inc. (HGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorHorne LLP
CEOCameron Durrant
Emplyoees5
Last AuditUE
CIK0001293310
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address533 Airport Boulevard
Suite 400
Burlingame, CA 94005
Websitehttps://www.humanigen.com
Facsimile-
Telephone+1 650 243-3100
Email-


Your Recent History
NASDAQ
HGEN
Humanigen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.